These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1994540)

  • 1. Detection of allograft endothelial cells of recipient origin following ABO-compatible, nonidentical cardiac transplantation.
    O'Connell JB; Renlund DG; Bristow MR; Hammond EH
    Transplantation; 1991 Feb; 51(2):438-42. PubMed ID: 1994540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intragraft expression of recipient-type ABO blood group antigens: long-term follow-up and histological features after liver transplantation.
    Tanaka Y; Haga H; Egawa H; Okuno T; Miyagawa-Hayashino A; Tsuruyama T; Kambe M; Marusawa H; Chiba T; Manabe T
    Liver Transpl; 2005 May; 11(5):547-54. PubMed ID: 15838883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection.
    Derhaag JG; Duijvestijn AM; Damoiseaux JG; van Breda Vriesman PJ
    Transplantation; 2000 May; 69(9):1899-906. PubMed ID: 10830229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.
    Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN
    Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO histo-blood group antigen expression on the graft endothelium long term after ABO-compatible, non-identical heart transplantation.
    Koestner SC; Kappeler A; Schaffner T; Carrel TP; Mohacsi PJ
    Xenotransplantation; 2006 Mar; 13(2):166-70. PubMed ID: 16623813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.
    Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR
    Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation.
    Koestner SC; Kappeler A; Schaffner T; Carrel TP; Nydegger UE; Mohacsi P
    Lancet; 2004 May; 363(9420):1523-5. PubMed ID: 15135601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome.
    Yamani MH; Haji SA; Starling RC; Tuzcu EM; Ratliff NB; Cook DJ; Abdo A; Crowe T; Secic M; McCarthy P; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):970-7. PubMed ID: 11897438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss.
    Khanna AK; Xu J; Uber PA; Burke AP; Baquet C; Mehra MR
    Circulation; 2009 Nov; 120(18):1814-21. PubMed ID: 19841304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
    Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO-incompatible heart transplantation in infants.
    West LJ; Pollock-Barziv SM; Dipchand AI; Lee KJ; Cardella CJ; Benson LN; Rebeyka IM; Coles JG
    N Engl J Med; 2001 Mar; 344(11):793-800. PubMed ID: 11248154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell chimerism after renal transplantation and vascular rejection.
    Lagaaij EL; Cramer-Knijnenburg GF; van Kemenade FJ; van Es LA; Bruijn JA; van Krieken JH
    Lancet; 2001 Jan; 357(9249):33-7. PubMed ID: 11197359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.